Indaptus Therapeutics Inc (INDP)

Nov 29, 2025

How buybacks impact Indaptus Therapeutics Inc. stock valuePortfolio Growth Summary & Real-Time Buy Signal Notifications - BỘ NỘI VỤ

Nov 29, 2025

Nov 29, 2025

Indaptus Therapeutics (NASDAQ:INDP) Rating Increased to Hold at Wall Street Zen - Defense World

Nov 29, 2025

Nov 28, 2025

Pullback Watch: How buybacks impact Indaptus Therapeutics Inc. stock valueMarket Weekly Review & Risk Controlled Stock Pick Alerts - moha.gov.vn

Nov 28, 2025

Nov 27, 2025

Indaptus Therapeutics Inc. (INDP) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Nov 27, 2025

Nov 24, 2025

Nuvalent (NUVL) Receives a New Rating from Truist Financial - The Globe and Mail

Nov 24, 2025

Nov 20, 2025

Indaptus Therapeutics (INDP) Price Target Decreased by 60.00% to 10.20 - MSN

Nov 20, 2025

Nov 19, 2025

Volume spikes in Indaptus Therapeutics Inc. stock – what they meanEarnings Risk Summary & Smart Investment Allocation Insights - newser.com

Nov 19, 2025

Nov 19, 2025

Ranking Indaptus Therapeutics Inc. among high performing stocks via toolsTrade Risk Assessment & Low Volatility Stock Suggestions - newser.com

Nov 19, 2025

Nov 19, 2025

Why Indaptus Therapeutics Inc. stock could see breakout soonPortfolio Return Report & Low Volatility Stock Recommendations - newser.com

Nov 19, 2025

Nov 19, 2025

Will Indaptus Therapeutics Inc. rebound enough to break evenJuly 2025 Recap & Expert Approved Momentum Ideas - newser.com

Nov 19, 2025

Nov 19, 2025

How high can Indaptus Therapeutics Inc. stock go2025 Technical Patterns & Real-Time Volume Analysis Alerts - newser.com

Nov 19, 2025

Nov 19, 2025

What momentum indicators show for Indaptus Therapeutics Inc. stockMarket Sentiment Summary & Daily Profit Focused Screening - newser.com

Nov 19, 2025

Nov 17, 2025

Indaptus Therapeutics 3Q Research and Development Expenses About $1.52M >INDP - 富途牛牛

Nov 17, 2025

Nov 17, 2025

Indaptus Therapeutics Chief Scientific Officer Dr. Michael Newman to Present at the Donor Selection & Cell Source Summit - The Manila Times

Nov 17, 2025

Nov 17, 2025

Why Is Indaptus Therapeutics, Inc. (INDP) Stock Down Today? - Meyka

Nov 17, 2025

Nov 17, 2025

Indaptus (Nasdaq: INDP) showcases Decoy20 to tackle donor cell variability - Stock Titan

Nov 17, 2025

Nov 17, 2025

Volatility clustering patterns for Indaptus Therapeutics Inc.Weekly Trade Analysis & Reliable Intraday Trade Alerts - newser.com

Nov 17, 2025

Nov 16, 2025

Does Indaptus Therapeutics Inc. fit your quant trading modelJuly 2025 Short Interest & Weekly High Conviction Trade Ideas - newser.com

Nov 16, 2025

Nov 16, 2025

Why retail investors pile into Indaptus Therapeutics Inc. stockWeekly Gains Report & Capital Efficiency Focused Strategies - newser.com

Nov 16, 2025

Nov 16, 2025

Can Indaptus Therapeutics Inc. stock double in next 5 yearsSwing Trade & Expert Curated Trade Setups - newser.com

Nov 16, 2025

Nov 16, 2025

Is Indaptus Therapeutics Inc. stock ready for a breakoutWeekly Stock Recap & Technical Buy Zone Confirmations - newser.com

Nov 16, 2025

Nov 15, 2025

Key resistance and support levels for Indaptus Therapeutics Inc.Weekly Profit Summary & Community Verified Watchlist Alerts - newser.com

Nov 15, 2025

Nov 15, 2025

Exit strategy if you’re trapped in Indaptus Therapeutics Inc.Weekly Volume Report & High Yield Equity Trading Tips - newser.com

Nov 15, 2025

Nov 14, 2025

Is Indaptus Therapeutics Inc. stock a defensive play in 2025Insider Buying & AI Forecasted Stock Moves - Fundação Cultural do Pará

Nov 14, 2025

Nov 12, 2025

Visual trend scoring systems applied to Indaptus Therapeutics Inc.July 2025 Summary & Precise Trade Entry Recommendations - newser.com

Nov 12, 2025

Nov 12, 2025

Indaptus Therapeutics Reports Q3 2025 Financial Results and Corporate Update - Quiver Quantitative

Nov 12, 2025

Nov 12, 2025

Indaptus Therapeutics Q3 profit beats estimates - MarketScreener

Nov 12, 2025

Nov 12, 2025

Indaptus Therapeutics Q3 2025 Financial Results and Corporate Update - TradingView

Nov 12, 2025

Nov 12, 2025

Indaptus Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update - The Manila Times

Nov 12, 2025

Nov 12, 2025

Indaptus Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 - MarketScreener

Nov 12, 2025

Nov 12, 2025

[10-Q] Indaptus Therapeutics, Inc. Quarterly Earnings Report | INDP SEC FilingForm 10-Q - Stock Titan

Nov 12, 2025

Nov 12, 2025

[8-K] Indaptus Therapeutics, Inc. Reports Material Event | INDP SEC FilingForm 8-K - Stock Titan

Nov 12, 2025

Nov 12, 2025

Indaptus (NASDAQ: INDP) completes Decoy20 safety lead-in; $5.8M cash, runway to Q1 2026 - Stock Titan

Nov 12, 2025